Taiwan DOH Mulls Emulating U.S. Ban On Avastin For Breast Cancer
This article was originally published in PharmAsia News
Executive Summary
Taiwan’s Department of Health said it would consider emulating U.S. action and banning Roche’s Avastin (bevacizumab) as a treatment for advanced forms of breast cancer.